by GlobeNewsWire | Sep 3, 2015 | Globe Newswire
ENGLEWOOD, N.J., Sept. 3, 2015 (GLOBE NEWSWIRE) — Point Capital Inc. (OTCQB:PTCI), “We produced a net increase in net assets resulting from operations for the second consecutive quarter after growing 25.6% in 2014. The companies in our portfolio have great...
by editor | Jan 26, 2013 | Asides, Blog
For news on PVCT, visit: http://stockguru.com//tag/pvct/ Provectus Pharmaceuticals, Inc. (OTCQB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced that its shares are now trading on the OTCQB marketplace through the OTC Markets...
by editor | Apr 27, 2011 | Latest Spotlights, Penny Stocks, Penny Stocks Alerts
DALLAS, TEXAS : StockGuru announces that Provectus Pharmaceutical Inc (OTCBB: PVCT)) is in the StockGuru Spotlight. Provectus Pharmaceuticals specializes in developing oncology and dermatology therapies. Its novel oncology drug PV-10 is designed to selectively...
by editor | Sep 14, 2010 | Latest Spotlights, StockGuru Blog
DALLAS, TEXAS : StockGuru announces that Provectus Pharmaceutical Inc (OTCBB: PVCT) is in the StockGuru Spotlight. Provectus Pharmaceuticals specializes in developing oncology and dermatology therapies. Its novel oncology drug PV-10 is designed to selectively...
